Cosmetic Products Containing Methylene Chloride
Introduction The cosmetics industry has evolved rapidly over the past decade, driven by innovation, consumer awareness, and stricter regulatory scrutiny. Among the many substances evaluated
Latest News
HHS Enables FDA Emergency Use of Animal Drugs to Combat New World Screwworm and Safeguard
In a decisive move to protect agricultural stability and food security, the U.S. Department of Health and Human Services (HHS) has authorized the Food and
Longtime FDA Innovator Appointed as Director of Center for Drug Evaluation and Research
The appointment of a seasoned innovator to lead the Center for Drug Evaluation and Research (CDER) marks a defining moment for the global pharmaceutical and
FDA Approves First-Ever Gene Therapy for Genetic Hearing Loss: A Transformational Milestone in Precision Medicine
The recent approval by the U.S. Food and Drug Administration of the first-ever gene therapy designed to treat genetic hearing loss marks a defining moment
The Silent Collapse: How Loss of Subcutaneous Fat Disrupts Collagen Signaling And Why No Formulation
The Silent Collapse: How Loss of Subcutaneous Fat Disrupts Collagen Signaling And Why No Formulation Can Fully Replace It By Eminent Global Research Solutions The
The Evolving Landscape of the Cosmetic Industry: Trends, Innovation, and Market Intelligence
The Evolving Landscape of the Cosmetic Industry: Trends, Innovation, and Market Intelligence The global cosmetic industry has transformed dramatically over the past decade, evolving from
Big Oil, Smarter Data: How AI Is Redefining the Energy Industry
The global energy sector is undergoing one of the most profound transformations in its history. Once driven primarily by physical assets—rigs, pipelines, refineries—it is now
Digital Infrastructure Funds Are Reshaping Telecom Ownership
Digital Infrastructure Funds Are Reshaping Telecom Ownership The global telecom industry is undergoing a structural transformation, and at the center of this shift is the
FDA’s Flexible Approach to Cell & Gene Therapy A Strategic Reset for Biopharma
The latest regulatory evolution from the U.S. Food and Drug Administration is not merely about introducing flexibility in cell and gene therapy (CGT) development—it represents